Company profile
Edesa Biotech, Inc.
NASDAQ:EDSABiotechnology: Pharmaceutical Preparations
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04401475 | phase2_3 | suspended | 2020-11-25 | 2024-12-01 | Edesa Biotech Inc. | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19 |
| NCT03680131 | phase2 | completed | 2019-10-15 | 2022-09-21 | Edesa Biotech Inc. | Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis |
FDA applications (0)
No records yet.